[시장보고서]ECG 일회용 시장 : 시장 규모, 점유율, 동향 분석 보고서 - 제품별, 환자 속성별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

ECG 일회용 시장 : 시장 규모, 점유율, 동향 분석 보고서 - 제품별, 환자 속성별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

ECG Disposable Market Size, Share & Trends Analysis Report By Product (Wet Gel Electrodes, Dry Electrodes), By Patient Demographics (Adult, Pediatric, Neonatal), By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030

상품코드 : 1726277

리서치사 : Grand View Research

발행일 : 2025년 04월

페이지 정보 : 영문 100 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,950

￦ 8,635,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950

￦ 10,087,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950

￦ 12,990,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

ECG 일회용 시장 규모 및 동향

세계의 ECG 일회용 시장 규모는 2024년에 5억 58만 달러로 평가되었고, 2025-2030년 CAGR 4.4%로 성장할 것으로 예측됩니다.

심장 마비, 부정맥, 심부전과 같은 CVD의 부담 증가로 인해 빈번하고 정확한 심장 모니터링이 필요합니다. ECG 일회용은 이 모니터링에서 중요한 역할을 하며 수요를 견인하고 있습니다. 예를 들어 WHO의 추정에 따르면 CVD는 세계 사인의 1위이며 매년 세계 사망률의 상당한 비중을 차지하고 있습니다. ECG 모니터를 필요로 하는 이런 많은 환자들이 일회용 전극이나 일회용 리드선의 필요성을 부추기고 있습니다.

심혈관계 질환(CVDs)으로 총칭되는 심장 질환의 높은 세계 이환율 및 증가는 ECG 일회용(심전도) 시장의 주요 촉진요인입니다. 이 표는 2021년 세계 심장병 유병률의 상승을 강조하고 있습니다.

고령자는 심혈관 질환이나 관련 건강 합병증에 걸리기 쉽기 때문에 고령자 증가는 ECG 일회용 시장의 중요한 촉진요인입니다. 고령이 되면 부정맥, 고혈압, 심부전 등의 심장질환에 이환할 가능성이 높아지기 때문에 심장 건강상태를 정기적으로 모니터링하는 수요가 높아집니다. 일회용으로 휴대 가능, 비용 대비 효과가 높고 사용하기 쉬운 ECG는 고령 환자의 심장 건강 상태를 지속적으로 모니터링하기 위한 효율적인 솔루션입니다. 고령화 사회의 만성 질환 증가, ECG 일회용 편의성과 저렴한 가격이 헬스케어 환경, 재택 케어 환경, 웰니스 모니터링에서의 채택을 가속화하여 시장 성장을 더욱 촉진하고 있습니다.

또한 가정이나 외래 케어 센터 등 기존 병원 이외의 환경에서 헬스케어 서비스를 제공하는 경향이 강해지고 있으며, 이러한 환경에서 환자를 모니터링하기 위한 편리하고 사용하기 쉬운 ECG 일회용에 대한 수요가 높아지고 있습니다. 예를 들어, 미국에는 현재 11,555개의 ASC가 있으며, 그 중에는 6,382개의 메디케어 인증 ASC와 5,173개의 비메디케어 인증 ASC가 포함되어 있습니다. 게다가 헬스케어 시설은 원내 감염(HAI)의 예방에 점점 힘을 쏟고 있습니다. ECG 일회용은 재사용 가능한 전극이나 리드선과 관련된 2차 오염의 위험을 배제하고 위생과 환자의 안전성을 유지하는데 있어서 바람직한 선택이 되고 있습니다. 감염 대책을 강조하는 규제 기관이나 병원의 프로토콜은, ECG 일회용 제품의 채용을 한층 더 뒷받침하고 있습니다.

지역별 시장 점유율 분석(2024년, 2030년)
지역별 시장 대시보드
세계 지역별 시장 현황
지역별 시장 점유율 및 주요 진출 기업(2024년)
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
시장 규모와 예측 및 동향 분석(2018-2030년)
ECG 일회용 시장 점유율 : 지역별(2024년, 2030년)(단위 : 100만 달러)
북미
- 미국
- 캐나다
- 멕시코
유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 덴마크
- 스웨덴
- 노르웨이
아시아태평양
- 중국
- 인도
- 일본
- 한국
- 태국
- 호주
라틴아메리카
- 브라질
- 아르헨티나
중동 및 아프리카
- 남아프리카
- 사우디아라비아
- 아랍에미리트(UAE)
- 쿠웨이트

제9장 경쟁 구도

주요 시장 진출기업에 의한 최근의 동향 및 영향 분석
기업 및 경쟁의 분류
벤더 상황
- 주요 리셀러 목록
- 주요 기업의 시장 점유율 분석(2024년)
주요 기업 프로파일
- 3M
- AMI ITALIA
- AthenaDiax.
- Baisheng Medical Equipment
- BioTekna
- BPL Medical Technologies
- Cardiolex
- ConMed
- Harvard Apparatus
- INTCO Medical
- Intelesens
- AB Medica Group
- LUMED
- Med-link Electronics Tech Co.
- Ambu A/S
- Nihon Kohden Europe
- Tenocom Medical Technology Co., Ltd

AJY

영문 목차

영문목차

ECG Disposable Market Size & Trends:

The global ECG disposable market size was estimated at USD 500.58 million in 2024 and is anticipated to grow at a CAGR of 4.4% from 2025 to 2030. The increasing global burden of CVDs, such as heart attacks, arrhythmias, and heart failure, necessitates frequent and accurate cardiac monitoring. Disposable ECG equipment plays a crucial role in this monitoring, driving its demand. For instance, the WHO estimates that CVDs are the leading cause of death worldwide, accounting for a significant percentage of global mortality each year. This large patient pool requiring ECG monitoring fuels the need for disposable electrodes and disposable lead wires.

The high and increasing global incidence of heart diseases, collectively known as cardiovascular diseases (CVDs), is a primary driver for the disposable Electrocardiogram (ECG) equipment market. The table highlight the rising prevalence of heart disease in the globe in 2021.

The growing geriatric population is a significant driver of the ECG disposable market, as older adults are more prone to cardiovascular diseases and related health complications. As individuals age, the likelihood of developing heart conditions such as arrhythmias, hypertension, and heart failure increases, leading to a higher demand for regular monitoring of heart health. Disposable, portable, cost-effective, and easy-to-use ECGs offer an efficient solution for continuous heart health monitoring in elderly patients. The rise in chronic diseases among the aging population and the convenience and affordability of disposable ECG devices are accelerating their adoption in healthcare settings, home care environments, and wellness monitoring, further driving market growth.

Moreover, the growing trend of delivering healthcare services outside traditional hospital settings, such as in homes and ambulatory care centers, is increasing the demand for convenient and user-friendly disposable ECG equipment to monitor patients in these environments. For instance, in the U.S., there are currently 11,555 ASCs, including 6,382 Medicare-certified ASCs and 5,173 non-Medicare-certified ASCs. Furthermore, healthcare facilities are increasingly focused on preventing hospital-acquired infections (HAIs). Disposable ECG equipment eliminates the risk of cross-contamination associated with reusable electrodes and lead wires, making it a preferred choice for maintaining hygiene and patient safety. Regulatory bodies and hospital protocols emphasizing infection control measures further propel the adoption of disposable ECG products.

Global ECG Disposable Market Report Segmentation

This report forecasts revenue & volume growth of the ECG disposable market and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global ECG disposable market report based on product, patient demographics, application, end-use, and region:

Product Type Outlook (Revenue, USD Million, 2018 - 2030)
Wet Gel Electrodes
Dry Electrodes
Hydrocolloid Electrodes
Foam Electrodes
Others
Patient Demographics Outlook (Revenue, USD Million, 2018 - 2030)
Adult
Pediatric
Neonatal
Application Outlook (Revenue, USD Million, 2018 - 2030)
Diagnostic
Monitoring
End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Ambulatory Care Centers
Others
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Asia Pacific
- Japan
- China
- India
- Thailand
- South Korea
- Australia
Latin America
- Brazil
- Argentina
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Market Definitions
1.3. Research Methodology
1.4. Information Procurement
- 1.4.1. Purchased Database
- 1.4.2. GVR's Internal Database
1.5. Details of Primary Research
- 1.5.1. Data for Primary Interviews in North America
- 1.5.2. Data for Primary Interviews in Europe
- 1.5.3. Data for Primary Interviews in Asia Pacific
- 1.5.4. Data for Primary Interviews in Latin America
- 1.5.5. Data for Primary Interviews in MEA
1.6. Market Formulation & Validation
1.7. Model Details
- 1.7.1. Commodity Flow Analysis (Model 1)
  - 1.7.1.1. Approach 1: Commodity Flow Approach
- 1.7.2. Volume price analysis (Model 2)
  - 1.7.2.1. Approach 2: Volume Price Analysis
1.8. Research Scope and Assumptions
- 1.8.1. List of Secondary Sources
- 1.8.2. List of Primary Sources
- 1.8.3. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. ECG Disposable Market Variables, Trends, & Scope

3.1. Market Introduction/Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
- 3.2.1. Market Drivers Analysis
  - 3.2.1.1. Rising Prevalence of Cardiovascular Diseases (CVDs)
  - 3.2.1.2. Growing Geriatric Population
  - 3.2.1.3. Infection Control and Hygiene Awareness
  - 3.2.1.4. Expansion of Telemedicine and Remote Monitoring
- 3.2.2. Market Restraints Analysis
  - 3.2.2.1. Skin Irritation and Allergic Reactions
  - 3.2.2.2. Availability of Reusable Alternatives
- 3.2.3. Market Opportunities Analysis
- 3.2.4. Market Challenges Analysis
3.3. ECG Disposable Market Analysis Tools
- 3.3.1. Porter's Analysis
  - 3.3.1.1. Bargaining Power of the Suppliers
  - 3.3.1.2. Bargaining Power of the Buyers
  - 3.3.1.3. Threats of Substitution
  - 3.3.1.4. Threats From New Entrants
  - 3.3.1.5. Competitive Rivalry
- 3.3.2. PESTEL Analysis
  - 3.3.2.1. Political Landscape
  - 3.3.2.2. Economic and Social Landscape
  - 3.3.2.3. Technological Landscape
  - 3.3.2.4. Environmental Landscape
  - 3.3.2.5. Legal Landscape

Chapter 4. ECG Disposable Market: Product Estimates & Trend Analysis

4.1. Definitions and Scope
4.2. Product Market Share, 2018 & 2030
4.3. Segment Dashboard
4.4. ECG Disposable Market by Product Outlook
4.5. Market Size & Forecasts and Trend Analysis, 2025 to 2030 for the following:
4.6. Wet Gel Electrodes
- 4.6.1. Wet Gel Electrodes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Dry Electrodes
- 4.7.1. Dry Electrodes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8. Hydrocolloid Electrodes
- 4.8.1. Hydrocolloid Electrodes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.9. Foam Electrodes
- 4.9.1. Foam Electrodes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.10. Others
- 4.10.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. ECG Disposable Market: Patient Demographics Estimates & Trend Analysis

5.1. Definitions and Scope
5.2. Patient Demographics Market Share, 2018 & 2030
5.3. Segment Dashboard
5.4. ECG Disposable Market by Patient Demographics Outlook
5.5. Market Size & Forecasts and Trend Analysis, 2025 to 2030 for the following:
5.6. Adult
- 5.6.1. Adult Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Pediatric
- 5.7.1. Pediatric Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8. Neonatal
- 5.8.1. Neonatal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. ECG Disposable Market: Application Estimates & Trend Analysis

6.1. Definitions and Scope
6.2. Application Market Share, 2018 & 2030
6.3. Segment Dashboard
6.4. ECG Disposable Market by Application Outlook
6.5. Market Size & Forecasts and Trend Analysis, 2025 to 2030 for the following:
6.6. Diagnostic
- 6.6.1. Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Monitoring
- 6.7.1. Monitoring Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. ECG Disposable Market: End Use Estimates & Trend Analysis

7.1. Definitions and Scope
7.2. End Use Market Share, 2018 & 2030
7.3. Segment Dashboard
7.4. ECG Disposable Market by End Use Outlook
7.5. Market Size & Forecasts and Trend Analysis, 2025 to 2030 for the following:
7.6. Hospitals
- 7.6.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Ambulatory Care Centers
- 7.7.1. Ambulatory Care Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8. Others
- 7.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. ECG Disposable Market: Regional Estimates & Trend Analysis, By Product, Patient Demographics, Application, End Use

8.1. Regional market share analysis, 2024 & 2030
8.2. Regional Market Dashboard
8.3. Global Regional Market Snapshot
8.4. Regional Market Share and Leading Players, 2024
- 8.4.1. North America
- 8.4.2. Europe
- 8.4.3. Asia Pacific
- 8.4.4. Latin America
- 8.4.5. Middle East and Africa
8.5. Market Size & Forecasts, and Trend Analysis, 2018 to 2030:
8.6. ECG Disposable Market Share, By Region, 2024 & 2030, USD Million
8.7. North America
- 8.7.1. North America ECG Disposable Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.7.2. U.S.
  - 8.7.2.1. Key Country Dynamics
  - 8.7.2.2. Competitive Scenario
  - 8.7.2.3. Regulatory Framework
  - 8.7.2.4. Reimbursement Scenario
  - 8.7.2.5. U.S. Market Estimates and Forecasts, 2018 - 2030
- 8.7.3. Canada
  - 8.7.3.1. Key Country Dynamics
  - 8.7.3.2. Competitive Scenario
  - 8.7.3.3. Regulatory Framework
  - 8.7.3.4. Reimbursement Scenario
  - 8.7.3.5. Canada Market Estimates and Forecasts, 2018 - 2030
- 8.7.4. Mexico
  - 8.7.4.1. Key Country Dynamics
  - 8.7.4.2. Competitive Scenario
  - 8.7.4.3. Regulatory Framework
  - 8.7.4.4. Reimbursement Scenario
  - 8.7.4.5. Mexico Market Estimates and Forecasts, 2018 - 2030
8.8. Europe
- 8.8.1. Europe ECG Disposable Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.8.2. UK
  - 8.8.2.1. Key Country Dynamics
  - 8.8.2.2. Competitive Scenario
  - 8.8.2.3. Regulatory Framework
  - 8.8.2.4. Reimbursement Scenario
  - 8.8.2.5. UK Market Estimates and Forecasts, 2018 - 2030
- 8.8.3. Germany
  - 8.8.3.1. Key Country Dynamics
  - 8.8.3.2. Competitive Scenario
  - 8.8.3.3. Regulatory Framework
  - 8.8.3.4. Reimbursement Scenario
  - 8.8.3.5. Germany Market Estimates and Forecasts, 2018 - 2030
- 8.8.4. France
  - 8.8.4.1. Key Country Dynamics
  - 8.8.4.2. Competitive Scenario
  - 8.8.4.3. Regulatory Framework
  - 8.8.4.4. Reimbursement Scenario
  - 8.8.4.5. France Market Estimates and Forecasts, 2018 - 2030
- 8.8.5. Italy
  - 8.8.5.1. Key Country Dynamics
  - 8.8.5.2. Competitive Scenario
  - 8.8.5.3. Regulatory Framework
  - 8.8.5.4. Reimbursement Scenario
  - 8.8.5.5. Italy Market Estimates and Forecasts, 2018 - 2030
- 8.8.6. Spain
  - 8.8.6.1. Key Country Dynamics
  - 8.8.6.2. Competitive Scenario
  - 8.8.6.3. Regulatory Framework
  - 8.8.6.4. Reimbursement Scenario
  - 8.8.6.5. Spain Market Estimates and Forecasts, 2018 - 2030
- 8.8.7. Denmark
  - 8.8.7.1. Key Country Dynamics
  - 8.8.7.2. Competitive Scenario
  - 8.8.7.3. Regulatory Framework
  - 8.8.7.4. Reimbursement Scenario
  - 8.8.7.5. Denmark Market Estimates and Forecasts, 2018 - 2030
- 8.8.8. Sweden
  - 8.8.8.1. Key Country Dynamics
  - 8.8.8.2. Competitive Scenario
  - 8.8.8.3. Regulatory Framework
  - 8.8.8.4. Reimbursement Scenario
  - 8.8.8.5. Sweden Market Estimates and Forecasts, 2018 - 2030
- 8.8.9. Norway
  - 8.8.9.1. Key Country Dynamics
  - 8.8.9.2. Competitive Scenario
  - 8.8.9.3. Regulatory Framework
  - 8.8.9.4. Reimbursement Scenario
  - 8.8.9.5. Norway Market Estimates and Forecasts, 2018 - 2030
8.9. Asia Pacific
- 8.9.1. Asia Pacific ECG Disposable Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.9.2. China
  - 8.9.2.1. Key Country Dynamics
  - 8.9.2.2. Competitive Scenario
  - 8.9.2.3. Regulatory Framework
  - 8.9.2.4. Reimbursement Scenario
  - 8.9.2.5. China Market Estimates and Forecasts, 2018 - 2030
- 8.9.3. India
  - 8.9.3.1. Key Country Dynamics
  - 8.9.3.2. Competitive Scenario
  - 8.9.3.3. Regulatory Framework
  - 8.9.3.4. Reimbursement Scenario
  - 8.9.3.5. India Market Estimates and Forecasts, 2018 - 2030
- 8.9.4. Japan
  - 8.9.4.1. Key Country Dynamics
  - 8.9.4.2. Competitive Scenario
  - 8.9.4.3. Regulatory Framework
  - 8.9.4.4. Reimbursement Scenario
  - 8.9.4.5. Japan Market Estimates and Forecasts, 2018 - 2030
- 8.9.5. South Korea
  - 8.9.5.1. Key Country Dynamics
  - 8.9.5.2. Competitive Scenario
  - 8.9.5.3. Regulatory Framework
  - 8.9.5.4. Reimbursement Scenario
  - 8.9.5.5. South Korea Market Estimates and Forecasts, 2018 - 2030
- 8.9.6. Thailand
  - 8.9.6.1. Key Country Dynamics
  - 8.9.6.2. Competitive Scenario
  - 8.9.6.3. Regulatory Framework
  - 8.9.6.4. Reimbursement Scenario
  - 8.9.6.5. Thailand Market Estimates and Forecasts, 2018 - 2030
- 8.9.7. Australia
  - 8.9.7.1. Key Country Dynamics
  - 8.9.7.2. Competitive Scenario
  - 8.9.7.3. Regulatory Framework
  - 8.9.7.4. Reimbursement Scenario
  - 8.9.7.5. Australia Market Estimates and Forecasts, 2018 - 2030
8.10. Latin America
- 8.10.1. Latin America ECG Disposable Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.10.2. Brazil
  - 8.10.2.1. Key Country Dynamics
  - 8.10.2.2. Competitive Scenario
  - 8.10.2.3. Regulatory Framework
  - 8.10.2.4. Reimbursement Scenario
  - 8.10.2.5. Brazil Market Estimates and Forecasts, 2018 - 2030
- 8.10.3. Argentina
  - 8.10.3.1. Key Country Dynamics
  - 8.10.3.2. Competitive Scenario
  - 8.10.3.3. Regulatory Framework
  - 8.10.3.4. Reimbursement Scenario
  - 8.10.3.5. Argentina Market Estimates and Forecasts, 2018 - 2030
8.11. Middle East and Africa
- 8.11.1. Middle East and Africa ECG Disposable Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.11.2. South Africa
  - 8.11.2.1. Key Country Dynamics
  - 8.11.2.2. Competitive Scenario
  - 8.11.2.3. Regulatory Framework
  - 8.11.2.4. Reimbursement Scenario
  - 8.11.2.5. South Africa Market Estimates and Forecasts, 2018 - 2030
- 8.11.3. Saudi Arabia
  - 8.11.3.1. Key Country Dynamics
  - 8.11.3.2. Competitive Scenario
  - 8.11.3.3. Regulatory Framework
  - 8.11.3.4. Reimbursement Scenario
  - 8.11.3.5. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
- 8.11.4. UAE
  - 8.11.4.1. Key Country Dynamics
  - 8.11.4.2. Competitive Scenario
  - 8.11.4.3. Regulatory Framework
  - 8.11.4.4. Reimbursement Scenario
  - 8.11.4.5. UAE Market Estimates and Forecasts, 2018 - 2030
- 8.11.5. Kuwait
  - 8.11.5.1. Key Country Dynamics
  - 8.11.5.2. Competitive Scenario
  - 8.11.5.3. Regulatory Framework
  - 8.11.5.4. Reimbursement Scenario
  - 8.11.5.5. Kuwait Market Estimates and Forecasts, 2018 - 2030

Chapter 9. Competitive Landscape

9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.3. Vendor Landscape
- 9.3.1. List of key distributors
- 9.3.2. Key Company Market Share Analysis, 2024
9.4. Key Company Profiles
- 9.4.1. 3M
  - 9.4.1.1. Participant's Overview
  - 9.4.1.2. Financial Performance
  - 9.4.1.3. Product Benchmarking
  - 9.4.1.4. Recent Developments/ Strategic Initiatives
- 9.4.2. A.M.I. ITALIA
  - 9.4.2.1. Participant's Overview
  - 9.4.2.2. Financial Performance
  - 9.4.2.3. Product Benchmarking
  - 9.4.2.4. Recent Developments/ Strategic Initiatives
- 9.4.3. AthenaDiax.
  - 9.4.3.1. Participant's Overview
  - 9.4.3.2. Financial Performance
  - 9.4.3.3. Product Benchmarking
  - 9.4.3.4. Recent Developments/ Strategic Initiatives
- 9.4.4. Baisheng Medical Equipment
  - 9.4.4.1. Participant's Overview
  - 9.4.4.2. Financial Performance
  - 9.4.4.3. Product Benchmarking
  - 9.4.4.4. Recent Developments/ Strategic Initiatives
- 9.4.5. BioTekna
  - 9.4.5.1. Participant's Overview
  - 9.4.5.2. Financial Performance
  - 9.4.5.3. Product Benchmarking
  - 9.4.5.4. Recent Developments/ Strategic Initiatives
- 9.4.6. BPL Medical Technologies
  - 9.4.6.1. Participant's Overview
  - 9.4.6.2. Financial Performance
  - 9.4.6.3. Product Benchmarking
  - 9.4.6.4. Recent Developments/ Strategic Initiatives
- 9.4.7. Cardiolex
  - 9.4.7.1. Participant's Overview
  - 9.4.7.2. Financial Performance
  - 9.4.7.3. Product Benchmarking
  - 9.4.7.4. Recent Developments/ Strategic Initiatives
- 9.4.8. ConMed
  - 9.4.8.1. Participant's Overview
  - 9.4.8.2. Financial Performance
  - 9.4.8.3. Product Benchmarking
  - 9.4.8.4. Recent Developments/ Strategic Initiatives
- 9.4.9. Harvard Apparatus
  - 9.4.9.1. Participant's Overview
  - 9.4.9.2. Financial Performance
  - 9.4.9.3. Product Benchmarking
  - 9.4.9.4. Recent Developments/ Strategic Initiatives
- 9.4.10. INTCO Medical
  - 9.4.10.1. Participant's Overview
  - 9.4.10.2. Financial Performance
  - 9.4.10.3. Product Benchmarking
  - 9.4.10.4. Recent Developments/ Strategic Initiatives
- 9.4.11. Intelesens
  - 9.4.11.1. Participant's Overview
  - 9.4.11.2. Financial Performance
  - 9.4.11.3. Product Benchmarking
  - 9.4.11.4. Recent Developments/ Strategic Initiatives
- 9.4.12. AB Medica Group
  - 9.4.12.1. Participant's Overview
  - 9.4.12.2. Financial Performance
  - 9.4.12.3. Product Benchmarking
  - 9.4.12.4. Recent Developments/ Strategic Initiatives
- 9.4.13. LUMED
  - 9.4.13.1. Participant's Overview
  - 9.4.13.2. Financial Performance
  - 9.4.13.3. Product Benchmarking
  - 9.4.13.4. Recent Developments/ Strategic Initiatives
- 9.4.14. Med-link Electronics Tech Co.
  - 9.4.14.1. Participant's Overview
  - 9.4.14.2. Financial Performance
  - 9.4.14.3. Product Benchmarking
  - 9.4.14.4. Recent Developments/ Strategic Initiatives
- 9.4.15. Ambu A/S
  - 9.4.15.1. Participant's Overview
  - 9.4.15.2. Financial Performance
  - 9.4.15.3. Product Benchmarking
  - 9.4.15.4. Recent Developments/ Strategic Initiatives
- 9.4.16. Nihon Kohden Europe
  - 9.4.16.1. Participant's Overview
  - 9.4.16.2. Financial Performance
  - 9.4.16.3. Product Benchmarking
  - 9.4.16.4. Recent Developments/ Strategic Initiatives
- 9.4.17. Tenocom Medical Technology Co., Ltd
  - 9.4.17.1. Participant's Overview
  - 9.4.17.2. Financial Performance
  - 9.4.17.3. Product Benchmarking
  - 9.4.17.4. Recent Developments/ Strategic Initiatives

한글목차

ECG 일회용 시장 규모 및 동향

목차

제1장 조사 방법 및 범위

제2장 주요 요약

제3장 ECG 일회용 시장의 변수, 동향 및 범위

제4장 ECG 일회용 시장 : 제품별 추정 및 동향 분석

제5장 ECG 일회용 시장 : 환자 인구별 추정 및 동향 분석

제6장 ECG 일회용 시장 : 용도별 추정 및 동향 분석

제7장 ECG 일회용 시장 : 최종 용도별 추정 및 동향 분석

제8장 ECG 일회용 시장 : 지역별 추정 및 동향 분석-제품별, 환자층별, 용도별, 최종 용도별